Cell and gene therapy investment strategy pivots as funding dries up

December 10, 2025
12:11 pm

Cell and gene therapy investment strategy pivots as funding dries up

According to a recent report by GlobalData, venture capital deals dropped by around 61% from 2021 to 2025. Golden Dayz via Shutterstock.com.

Companies looking to push into the gene therapy (CGT) sector are navigating a more selective funding landscape amid a wider downturn in venture…

Share this article

Japanese regulators want private sector’s help to fight crypto money laundering – DL News

March 2, 2026

Qivalis in talks with crypto exchanges ahead of euro stablecoin launch

March 2, 2026

Iranian crypto outflows jump 700% minutes after airstrikes, Elliptic says

March 2, 2026

3 Long-Term Investing Strategies to Really Internalize From the Greatest Investor of All Time

March 2, 2026

Crypto Funds Attract $1 Billion After Prolonged Outflows

March 2, 2026

British Airways owner IAG sees stock price plummet as FTSE 100 falls in wake of Iran strikes

March 2, 2026

Chinese banks freeze accounts over crypto memos

March 2, 2026

South Korea Probes $4.8 Million Crypto Theft After Tax Agency Leak

March 2, 2026